Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

Clinical trial NCT06126497 · COMPLETED

Trial details

NCT number: NCT06126497
Sponsor: Suven Life Sciences Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2024-02-05
Primary completion: 2024-07-19
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.